Contraccezione ormonale, HRT e rischio tromboembolico

More documents

Recommendations

Info

Farley et al. J Epidemiol Community Health 1998; 52
ACOG – controindications - History of thromboembolic disease - Cigarette smoking or obesity in women > 35 years - Hypertension in women with vascular disease or > 35 years - Hypertriglyceridemia - Coronary artery disease - Congestive heart failure - Cerebrovascular disease - Migraine headaches - Systemic lupus erythematosus with vascular disease, nephritis, or antiphospholipid antibodies - Less than 3 weeks postpartum* ACOG. Obstet Gynecol 2006;107:1453
Page 1 and 2: Contraccezione ormonale, HRT e risc
Page 3 and 4: La COC e’ e un fattore di rischio
Page 5 and 6: Vandenbroucke et al. NEJM 2003;344
Page 7 and 8: Farley et al. J Epidemiol Community
Page 9 and 10: Farley et al. Contraception 1998;57
Page 17 and 18: Rischio di TEV età et correlato <
Page 21 and 22: Fattore V di Leiden e COC FV Leiden
Page 23 and 24: Cost-effectiveness Cost effectivene
Page 27: RR Etinyl-E 20 ug 0.9-1.7 Etinyl-E
Page 31 and 32: 1. Quante cause di iperomocisteinem
Page 33 and 34: 2. Quanto è frequente la mutazione

Contraccezione ormonale, HRT e rischio tromboembolico

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?